TGF-β had a complex role in tumor immunity, hampering the ability of T cells to infiltrate tumors, reducing their effector functions, and promoting the differentiation of peripheral CD4+ T cells into Tregs, potentially limiting the host’s natural defense against cancer [127]. This evidence concerns the gene CD4 and neoplasm.